These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38146652)

  • 1. Effect of Flecainide and Ibutilide Alone and in Combination to Terminate and Prevent Recurrence of Atrial Fibrillation.
    Burashnikov A; Di Diego JM; Patocskai B; Echt DS; Belardinelli L; Antzelevitch C
    Circ Arrhythm Electrophysiol; 2024 Jan; 17(1):e012454. PubMed ID: 38146652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Efficacy of I Na Block to Cardiovert Atrial Fibrillation Is Enhanced by Inhibition of I K1.
    Burashnikov A; Antzelevitch C
    J Cardiovasc Pharmacol; 2024 Oct; 84(4):434-439. PubMed ID: 39115816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild elevation of extracellular potassium greatly potentiates the effect of sodium channel block to cardiovert atrial fibrillation: The Lankenau approach.
    Burashnikov A; Antzelevitch C
    Heart Rhythm; 2023 Sep; 20(9):1257-1264. PubMed ID: 37169158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consequences of atrial electrical remodeling for the anti-arrhythmic action of class IC and class III drugs.
    Duytschaever M; Blaauw Y; Allessie M
    Cardiovasc Res; 2005 Jul; 67(1):69-76. PubMed ID: 15949471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat.
    Blaauw Y; Schotten U; van Hunnik A; Neuberger HR; Allessie MA
    Cardiovasc Res; 2007 Jul; 75(1):89-98. PubMed ID: 17466958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapericardial ibutilide administration fails to terminate pacing-induced sustained atrial fibrillation in dogs.
    Vereckei A; Gorski JC; Ujhelyi M; Mehra R; Zipes DP
    Cardiovasc Drugs Ther; 2004 Jul; 18(4):269-77. PubMed ID: 15367824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents.
    Hongo RH; Themistoclakis S; Raviele A; Bonso A; Rossillo A; Glatter KA; Yang Y; Scheinman MM
    J Am Coll Cardiol; 2004 Aug; 44(4):864-8. PubMed ID: 15312873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation.
    Liu G; Xue X; Gao C; Huang J; Qi D; Zhang Y; Dong JZ; Ma CS; Yan GX
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28522677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset.
    Reisinger J; Gatterer E; Lang W; Vanicek T; Eisserer G; Bachleitner T; Niemeth C; Aicher F; Grander W; Heinze G; Kühn P; Siostrzonek P
    Eur Heart J; 2004 Aug; 25(15):1318-24. PubMed ID: 15288159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy.
    Glatter K; Yang Y; Chatterjee K; Modin G; Cheng J; Kayser S; Scheinman MM
    Circulation; 2001 Jan; 103(2):253-7. PubMed ID: 11208685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects on drug concentrations, electrophysiologic parameters, and termination of atrial fibrillation in dogs when procainamide and ibutilide are delivered into the right atrium versus intravenously.
    Vereckei A; Warman E; Mehra R; Zipes DP
    J Cardiovasc Electrophysiol; 2001 Mar; 12(3):330-6. PubMed ID: 11291807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter.
    Howard PA
    Ann Pharmacother; 1999 Jan; 33(1):38-47. PubMed ID: 9972384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol.
    Wijffels MC; Dorland R; Allessie MA
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):178-93. PubMed ID: 10090222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-density mapping of pulmonary veins and left atrium during ibutilide administration in a canine model of sustained atrial fibrillation.
    Chou CC; Zhou S; Tan AY; Hayashi H; Nihei M; Chen PS
    Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2704-13. PubMed ID: 16055519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single dose of ibutilide for conversion of persistent atrial fibrillation after radiofrequency ablation.
    Hou Y; Fang PH; Liu J; Li XF; Hu JQ; Zhang S
    Chin Med J (Engl); 2011 Mar; 124(5):710-3. PubMed ID: 21518563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation.
    Nair M; George LK; Koshy SK
    J Am Board Fam Med; 2011; 24(1):86-92. PubMed ID: 21209348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat.
    Eijsbouts S; Ausma J; Blaauw Y; Schotten U; Duytschaever M; Allessie MA
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):648-54. PubMed ID: 16836716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
    Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
    J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic enhancement of atrial electrical defibrillation efficacy: role of ibutilide.
    Khoury DS; Assar MD; Sun H
    J Interv Card Electrophysiol; 1997 Dec; 1(4):291-8. PubMed ID: 9869983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of verapamil and ibutilide on atrial fibrillation and postfibrillation atrial refractoriness.
    Sticherling C; Hsu W; Tada H; Bares AC; Oral H; Pelosi F; Knight BP; Strickberger SA; Morady F
    J Cardiovasc Electrophysiol; 2002 Feb; 13(2):151-7. PubMed ID: 11900290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.